Related by context. Frequent words. (Click for all words.) 69 hepatocellular carcinoma HCC 67 gastrointestinal stromal tumors 67 metastatic renal cell carcinoma 66 vandetanib 65 lupus nephritis 65 axitinib 65 chronic lymphocytic leukemia CLL 64 castration resistant prostate cancer 64 Everolimus 64 Erlotinib 64 Torisel 64 neuroendocrine tumors 64 medullary thyroid cancer 64 malignant pleural mesothelioma 64 androgen independent 64 interferon alfa 64 Phenoptin 63 hypoparathyroidism 63 chronic myeloid leukemia CML 63 liver metastases 63 systemic lupus erythematosus SLE 62 abiraterone 62 recurrent ovarian cancer 62 biologic therapy 62 decitabine 62 secondary hyperparathyroidism 62 sunitinib 62 vinorelbine 62 BAY #-# 62 relapsing remitting multiple sclerosis 62 chronic HBV infection 62 Alemtuzumab 62 chronic HCV infection 62 relapsed multiple myeloma 62 EGFR inhibitors 62 EGFR mutations 61 acute myelogenous leukemia AML 61 relapsed refractory multiple myeloma 61 double blinded placebo 61 Voreloxin 61 xenograft models 61 Jevtana 61 CMV disease 61 eltrombopag 61 refractory multiple myeloma 61 neoadjuvant 61 diabetic neuropathic pain 61 placebo controlled clinical 61 tocilizumab 61 SUTENT 61 advanced NSCLC 61 non squamous 61 Nexavar ® 61 lymphoma CTCL 61 hepatitis C HCV 61 anakinra 61 bone metastasis 61 investigational compounds 61 ponatinib 61 nilotinib 61 Lenalidomide 60 Cyclosporine 60 octreotide 60 Acute Myeloid Leukemia AML 60 fibromyalgia syndrome 60 NOXAFIL 60 Laquinimod 60 dasatinib 60 cutaneous T cell 60 idiopathic pulmonary fibrosis IPF 60 HER2 negative 60 TREANDA 60 SCH # 60 tyrosine kinase inhibitor 60 angiogenesis inhibitor 60 FTY# 60 chronic ITP 60 systemic lupus erythematosus 60 LY# [003] 60 chronic HCV 60 hepatocellular carcinoma 60 everolimus 60 Combination therapy 60 hypercalcemia 60 T2DM 60 anticancer therapy 60 telbivudine 60 myelodysplastic syndrome MDS 60 temsirolimus 60 hepatotoxicity 60 TORISEL 60 Sorafenib 60 dacarbazine 60 HER2 positive breast cancer 59 riluzole 59 ZYBRESTAT 59 HER2 positive metastatic breast 59 eribulin 59 daclizumab 59 azacitidine 59 DLBCL